Overview
The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.
Description
The purpose of this study is to compare serum bilirubin levels with non-invasive bilirubin measurements in neonates during the first 12 to 192 hours of life using the "Picterus Jaundice Pro" smartphone application with a proprietary calibration card placed over the neonate's sternum. We will also validate the accuracy of Picterus Jaundice Pro bilirubin measurements before and after phototherapy treatment.
Eligibility
Inclusion Criteria:
- the patient is free of skin rash, bruising, or other medical conditions that can interfere with transcutaneous measurement
- (preterm) < = 35 weeks gestational age
- (term) > 35 weeks gestational age
- the patient has not been excluded by PI discretion.
Exclusion Criteria:
- Neonates will be excluded from participation if all four inclusion criteria listed above are not met.